Clear and logical regulatory guidelines on the process and requirements for approval of health apps and wearable sensors will be essential for the digital medicine sector to unleash its full potential.
This is a preview of subscription content, log in via an institution to check access.
References
Medical Device Data Systems Final Rule, 76 FR 8637 FDA (2011).
US Department of Health and Human Services (HHS). FDA. Mobile Medical Applications: Guidance for Industry and FDA Staff (CDRH, 9 February 2015).
HHS. FDA. General Wellness: Policy for Low Risk Devices - Draft Guidance for Industry and FDA Staff. (CDRH, 20 January 2015).
HHS. FDA. Medical Device Data Systems, Medical Image Storage Devices, and Medical Image Communications Devices - Guidance for Industry and FDA Staff (CDRH, CBER, 9 February 2015).
US FDA. Examples of MMAs the FDA Regulates. HHS. 5 June 2015. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ConnectedHealth/MobileMedicalApplications/ucm368743.htm
US FDA. Examples of Mobile Apps For Which the FDA Will Exercise Enforcement Discretion. HHS. 5 June 2015. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ConnectedHealth/MobileMedicalApplications/ucm368744.htm
FDA. Federal Communications Commission. FDASIA Health IT Report: Proposed Strategy and Recommendations for a Risk-Based Framework (The Office of the National Coordinator for Health Information Technology, April 2014).
European Commission. DG Health and Consumers. Guidelines on the Qualification and Classification of Standalone Software Used in Healthcare within the Regulatory Framework of Medical Devices (January 2012).
Lakemedelsverket Medical Products Agency. Medical Information Systems: Guidance for Qualification and Classification of Standalone Software with a Medical Purpose (31 October 2012).
Elenko, E., Underwood, L. & Zohar, D. Nat. Biotechnol. 33, 456–461 (2015).
HHS. FDA. Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices (CDRH, CBER, 11 May 2015).
HHS. FDA. General Principles of Software Validation; Final Guidance for Industry and FDA Staff (CDRH, CBER, 11 January 2002).
HHS. FDA. Guidance for Industry and FDA Staff: Classification of Products as Drugs and Devices & Additional Product Classification Issues. Office of Combination Products in the Office of the Commissioner (CBER, Center for Drug Evaluation and Research, CDRH, June 2011).
FTC. FTC approves final settlement orders against marketers who claimed their mobile apps could cure acne (FTC, 25 October 2011).
FTC. FTC approves final order barring company from making unsubstantiated claims related to products' “Brain Training” capabilities (FTC, 9 April 2015).
FTC. FTC cracks down on marketers of “Melanoma Detection” apps (FTC, 23 February 2015).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
PureTech is actively forming companies in the digital medicine area, including Akili, which is mentioned in the article.
Rights and permissions
About this article
Cite this article
Elenko, E., Speier, A. & Zohar, D. A regulatory framework emerges for digital medicine. Nat Biotechnol 33, 697–702 (2015). https://doi.org/10.1038/nbt.3284
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.3284
- Springer Nature America, Inc.
This article is cited by
-
Digital health rules and regulations: an overview
CSI Transactions on ICT (2023)
-
Digital Tools—Regulatory Considerations for Application in Clinical Trials
Therapeutic Innovation & Regulatory Science (2023)
-
Artificial Intelligence and Medical Humanities
Journal of Medical Humanities (2022)
-
Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group
Diabetologia (2020)
-
Digital medicine's march on chronic disease
Nature Biotechnology (2016)